Drug middlemen illegally drive up the cost of insulin, FTC says

Drug middlemen illegally drive up the cost of insulin, FTC says

Federal regulators are accusing the country’s three largest pharmacy benefit managers of illegally driving up the cost of insulin in the U.S., while making it harder for patients to obtain cheaper versions of the life-saving drug.  The companies — CVS-owned Caremark Rx, Cigna Group’s Express Scripts and UnitedHealth Group’s Optum Rx — acted in ways … Read more

Dexcom launches Stelo, its first over-the-counter continuous glucose monitor

Dexcom launches Stelo, its first over-the-counter continuous glucose monitor

Zoom In IconArrows pointing outwards User wearing Stelo CGM from Dexcom. Courtesy of Dexcom Dexcom on Monday announced its new over-the-counter continuous glucose monitor Stelo is officially available for purchase in the U.S. Glucose is a type of sugar people receive from food, and it’s the body’s main source of energy. Continuous glucose monitors, or … Read more

New Covid shots from Pfizer, Moderna, what to know

New Covid shots from Pfizer, Moderna, what to know

Moderna Covid-19 Vaccine mRNA 2024-2025 formula. Courtesy: Moderna A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. It’s that time of the year again. A new round of Covid shots is on its way to Americans.  … Read more

FDA authorizes Novavax Covid vaccine targeting JN.1

FDA authorizes Novavax Covid vaccine targeting JN.1

A vial labelled “Novavax V COVID-19 Vaccine” is seen in this illustration taken January 16, 2022.  Dado Ruvic | Reuters The Food and Drug Administration authorized Novavax‘s updated protein-based Covid vaccine for emergency use in people ages 12 and up on Friday, paving the way for the shot to compete with Pfizer and Moderna‘s jabs … Read more

We’re taking a nearly 300% profit on a hot drug stock

We’re taking a nearly 300% profit on a hot drug stock

Shortly after the opening bell, we’ll be selling 10 shares of Eli Lilly at roughly $958 each. Following Monday’s trade, Jim Cramer’s Charitable Trust will own 100 shares of LLY, decreasing its weighting to 2.85% from about 3.13%. Now that we are no longer restricted, we are selling some Eli Lilly shares. We downgraded Lilly … Read more